Artificial Lung Market, By Product Type (Extracorporeal Membrane Oxygenation (ECMO) Systems (Veno-Arterial (VA) ECMO, Veno-Venous (VV) ECMO), Paracorporeal Artificial Lungs (Pumpless Paracorporeal Devices, Pump-Assisted Paracorporeal Devices), and Implantable Artificial Lungs (Intrathoracic Devices, Others (Oxygenators)), By Technology (Perfusion Systems, Membrane Oxygenation Technology, Microfluidic Oxygenators, Biohybrid Systems, Pumpless Gas Exchange Systems, and Others (3D-Printed Artificial Lung Constructs, etc.)), By Portability (Stationary Systems, Portable Systems, and Wearable Systems), By Application (Lung Transplant Support (Bridge-to-Transplant), Acute Respiratory Distress Syndrome (ARDS), Chronic Respiratory Conditions (COPD), Pulmonary Hypertension, Cystic Fibrosis), and Others (Coronary Artery Bypass Grafting, etc.)), By Patient Type (Neonates, Pediatric, and Adult), By End User (Hospitals, Transplant Centers, Ambulatory Surgical Centers, Emergency and Trauma Centers, Home Care Settings (for wearable devices), and Others (Research Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)